Award
National Cancer Institute 5R01CA269788-05
IDP mediated transcriptional stabilization as a cause of AML
Recipient
Children's Hospital of Philadelphia
Award Amount
$240,090.00
Ceiling
$240,090.00
Awarded
March 25, 2026
Identifier
5R01CA269788-05
Award for research on the role of MN1 in AML and therapeutic strategies, funded by NCI with a project duration of one year starting April 2026.
Description
The project focuses on the role of MN1 in AML and potential therapeutic strategies. It is funded by the National Cancer Institute (NCI), part of NIH. The project duration is from April 1, 2026, to March 31, 2027.